Yantai Zhenghai Bio-Tech Co Ltd (SHE:300653) — Stock Price
Yantai Zhenghai Bio-Tech Co Ltd (SHE:300653) is currently trading at CN¥15.35 CNY, down 0.45% today. Over the past 52 weeks, shares have ranged between CN¥13.54 and CN¥22.78. This page tracks Yantai Zhenghai Bio-Tech Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 300653 market cap.
Yantai Zhenghai Bio-Tech Co Ltd (300653) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Yantai Zhenghai Bio-Tech Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Yantai Zhenghai Bio-Tech Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Yantai Zhenghai Bio-Tech Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CN¥363.23 Million | CN¥413.65 Million | CN¥433.22 Million | CN¥400.18 Million | CN¥293.28 Million |
| Cost of Revenue | CN¥44.89 Million | CN¥41.77 Million | CN¥48.86 Million | CN¥43.60 Million | CN¥22.79 Million |
| Gross Profit | CN¥318.34 Million | CN¥371.88 Million | CN¥384.37 Million | CN¥356.58 Million | CN¥270.49 Million |
| Research & Development | CN¥39.52 Million | CN¥44.05 Million | CN¥37.55 Million | CN¥35.18 Million | CN¥26.57 Million |
| SG&A | CN¥6.59 Million | CN¥7.07 Million | CN¥8.43 Million | CN¥10.75 Million | CN¥8.76 Million |
| Total Operating Expenses | CN¥165.83 Million | CN¥153.31 Million | CN¥179.21 Million | CN¥182.03 Million | CN¥147.45 Million |
| Operating Income | CN¥152.51 Million | CN¥218.57 Million | CN¥212.07 Million | CN¥191.83 Million | CN¥133.71 Million |
| EBITDA | CN¥174.98 Million | CN¥239.62 Million | CN¥231.95 Million | CN¥209.54 Million | CN¥129.21 Million |
| EBIT | CN¥152.39 Million | CN¥219.11 Million | CN¥212.13 Million | CN¥191.60 Million | CN¥123.03 Million |
| Interest Expense | CN¥236.85K | CN¥5.14K | CN¥137.36 | CN¥26.16K | CN¥5.11K |
| Income Before Tax | CN¥152.38 Million | CN¥218.40 Million | CN¥212.11 Million | CN¥191.58 Million | CN¥136.48 Million |
| Income Tax Expense | CN¥17.74 Million | CN¥27.44 Million | CN¥26.67 Million | CN¥23.03 Million | CN¥18.15 Million |
| Net Income | CN¥134.64 Million | CN¥190.96 Million | CN¥185.44 Million | CN¥168.55 Million | CN¥118.33 Million |
Yantai Zhenghai Bio-Tech Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Yantai Zhenghai Bio-Tech Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | CN¥980.11 Million | CN¥1.05 Billion | CN¥986.90 Million | CN¥928.92 Million | CN¥805.54 Million |
| Total Current Assets | CN¥712.70 Million | CN¥770.63 Million | CN¥710.01 Million | CN¥663.38 Million | CN¥527.08 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥505.43 Million | CN¥598.61 Million | CN¥534.21 Million | CN¥445.18 Million | CN¥251.55 Million |
| Net Receivables | CN¥51.41 Million | CN¥55.39 Million | CN¥49.61 Million | CN¥51.74 Million | CN¥55.47 Million |
| Inventory | CN¥35.18 Million | CN¥36.72 Million | CN¥40.69 Million | CN¥33.98 Million | CN¥23.64 Million |
| Property, Plant & Equipment | — | — | CN¥228.03 Million | CN¥219.79 Million | CN¥234.04 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CN¥91.33 Million | CN¥105.76 Million | CN¥121.80 Million | CN¥143.65 Million | CN¥158.82 Million |
| Total Current Liabilities | CN¥80.79 Million | CN¥90.00 Million | CN¥105.61 Million | CN¥126.03 Million | CN¥144.95 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | CN¥-116.84 Million | CN¥-76.58 Million | CN¥-57.34 Million | CN¥-113.23 Million | CN¥-166.89 Million |
| Total Stockholder Equity | CN¥888.78 Million | CN¥948.07 Million | CN¥865.11 Million | CN¥785.27 Million | CN¥646.72 Million |
| Retained Earnings | CN¥490.08 Million | CN¥499.44 Million | CN¥435.59 Million | CN¥374.30 Million | CN¥252.61 Million |
Yantai Zhenghai Bio-Tech Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Yantai Zhenghai Bio-Tech Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥151.38 Million | CN¥180.48 Million | CN¥187.84 Million | CN¥166.13 Million | CN¥118.43 Million |
| Capital Expenditures | CN¥15.57 Million | CN¥31.88 Million | CN¥56.06 Million | CN¥9.82 Million | CN¥103.03 Million |
| Free Cash Flow | CN¥135.81 Million | CN¥148.60 Million | CN¥131.78 Million | CN¥156.31 Million | CN¥15.41 Million |
| Investing Cash Flow | CN¥95.66 Million | CN¥-86.13 Million | CN¥-137.84 Million | CN¥-187.33 Million | CN¥27.80 Million |
| Financing Cash Flow | CN¥-193.93 Million | CN¥-108.01 Million | CN¥-105.60 Million | CN¥-30.02 Million | CN¥-60.07 Million |
| Dividends Paid | CN¥144.00 Million | CN¥108.00 Million | CN¥105.60 Million | CN¥30.02 Million | CN¥60.07 Million |
| Stock-Based Compensation | — | — | CN¥1.35 Million | CN¥-7.63 Million | CN¥10.76K |
| Depreciation | CN¥22.59 Million | CN¥20.52 Million | CN¥19.10 Million | CN¥17.74 Million | CN¥6.18 Million |
| Change in Cash | CN¥53.11 Million | CN¥1.52 Million | CN¥-55.60 Million | CN¥-51.21 Million | CN¥86.16 Million |
Yantai Zhenghai Bio-Tech Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Yantai Zhenghai Bio-Tech Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 0.12 | — | — |
| Jun 30, 2025 | 0.11 | — | — |
| Apr 21, 2025 | 0.05 | — | — |
| Oct 22, 2024 | 0.22 | — | — |
| Aug 05, 2024 | 0.25 | — | — |
| Apr 28, 2024 | 0.24 | — | — |
| Oct 23, 2023 | 0.21 | — | — |
| Jul 31, 2023 | 0.31 | — | — |